Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TZP-102 for diabetic gastroparesis gastric emptying (Phase 2, randomized, double-blind, placebo-controlled)
2008-007226-19Phase 2Completed
- Sponsor
- Tranzyme Pharma
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gastroparesis comparing TZP-102 once daily with Placebo once daily (2 arms). Primary endpoints: Change from baseline in gastric half-emptying time (T½) on Day 1 and Change from baseline in gastric half-emptying time (T½) on Day 28. Started Mar 2009; status: completed.
02
Drugs
TZP-102
03
Conditions
gastroparesis
Beyond the preview
Go deeper on 2008-007226-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007226-19.